Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effectiveness of Embrace Scar Therapy Device After Cutaneous Wound Closure

NCT: NCT03294863 · TERMINATED

NCT IDNCT03294863
StatusTERMINATED
Start Date2017-03-15
Completion2025-12-08
SponsorUniversity of California, Davis (OTHER)
First posted
Last updated

Brief Summary

The purpose of this study is to determine whether the use of the embrace device after repair of linear cutaneous surgery wounds improves scar cosmesis.

Frequently Asked Questions

What is Effectiveness of Embrace Scar Therapy Device After Cutaneous Wound Closure?

Effectiveness of Embrace Scar Therapy Device After Cutaneous Wound Closure is a clinical trial registered under NCT03294863. Current status: TERMINATED.

What is the status of NCT03294863?

The current status of NCT03294863 (Effectiveness of Embrace Scar Therapy Device After Cutaneous Wound Closure) is: TERMINATED.

When did Effectiveness of Embrace Scar Therapy Device After Cutaneous Wound Closure start?

Effectiveness of Embrace Scar Therapy Device After Cutaneous Wound Closure started on 2017-03-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑